Eli Lilly (Germany) Market Value
| LLY Stock | EUR 751.40 5.60 0.75% |
| Symbol | Eli |
Eli Lilly 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eli Lilly's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eli Lilly.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Eli Lilly on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Eli Lilly and or generate 0.0% return on investment in Eli Lilly over 720 days. Eli Lilly is related to or competes with Premier Foods, Astral Foods, Ramsay Health, ATRYS HEALTH, EHEALTH, and Performance Food. Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide More
Eli Lilly Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eli Lilly's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eli Lilly and upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 10.81 | |||
| Value At Risk | (3.73) | |||
| Potential Upside | 2.88 |
Eli Lilly Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eli Lilly's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eli Lilly's standard deviation. In reality, there are many statistical measures that can use Eli Lilly historical prices to predict the future Eli Lilly's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.31) |
Eli Lilly Backtested Returns
Eli Lilly secures Sharpe Ratio (or Efficiency) of -0.0922, which denotes the company had a -0.0922% return per unit of risk over the last 3 months. Eli Lilly and exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eli Lilly's Variance of 4.49, mean deviation of 1.45, and Standard Deviation of 2.12 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.63, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eli Lilly's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eli Lilly is expected to be smaller as well. At this point, Eli Lilly has a negative expected return of -0.2%. Please make sure to confirm Eli Lilly's potential upside, daily balance of power, and the relationship between the maximum drawdown and kurtosis , to decide if Eli Lilly performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.66 |
Good predictability
Eli Lilly and has good predictability. Overlapping area represents the amount of predictability between Eli Lilly time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eli Lilly price movement. The serial correlation of 0.66 indicates that around 66.0% of current Eli Lilly price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 8927.27 |
Eli Lilly lagged returns against current returns
Autocorrelation, which is Eli Lilly stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eli Lilly's stock expected returns. We can calculate the autocorrelation of Eli Lilly returns to help us make a trade decision. For example, suppose you find that Eli Lilly has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eli Lilly regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eli Lilly stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eli Lilly stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eli Lilly stock over time.
Current vs Lagged Prices |
| Timeline |
Eli Lilly Lagged Returns
When evaluating Eli Lilly's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eli Lilly stock have on its future price. Eli Lilly autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eli Lilly autocorrelation shows the relationship between Eli Lilly stock current value and its past values and can show if there is a momentum factor associated with investing in Eli Lilly and.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Eli Stock
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:Check out Eli Lilly Correlation, Eli Lilly Volatility and Eli Lilly Alpha and Beta module to complement your research on Eli Lilly. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Eli Lilly technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.